IL-1β enables CNS access to CCR2hi monocytes and the generation of pathogenic cells through GM-CSF released by CNS endothelial cells

IL-1β enables CNS access to CCR2hi monocytes and the generation of pathogenic cells through GM-CSF released by CNS endothelial cells
复制标题

DOI:
10.1073/pnas.1714948115
复制
发表时间:
2018-02-06
影响因子:
11.1
通讯作者:
Lacroix, Steve
Lacroix, Steve
中科院分区:
综合性期刊1区
文献类型:
--
作者:
Pare, Alexandre;Mailhot, Benoit;Lacroix, Steve

文献摘要

被引文献

相似文献

限制致病性CNS炎症的分子干预用于治疗自身免疫性疾病,如多发性硬化症(MS)。值得注意的是,IL-1 β基因敲除小鼠对实验性自身免疫性脑脊髓炎(EAE),MS的动物模型具有高度抗性。在这里,我们表明,干扰IL-1 β/IL-1 R1轴严重损害了髓系细胞穿过中枢神经系统(CNS)内皮细胞(EC)的迁移。值得注意的是,我们报道炎症性CCR 2(hi)单核细胞表达IL-1 β有利于它们在EAE发作前进入脊髓。在用IL-1 β激活后,CNS EC释放GM-CSF,GM-CSF进而将单核细胞转化为抗原呈递细胞(APC)。因此,脊髓浸润的单核细胞来源的APC与分裂的CD 4(+)T细胞相关。从IL-1 β-感受态髓样细胞和CD 4(+)T细胞之间的相互作用释放的因子对神经元具有高度毒性。总之,我们的研究结果表明,IL-1 β信号转导是一个切入点,针对启动和恶化的神经炎症。
Molecular interventions that limit pathogenic CNS inflammation are used to treat autoimmune conditions such as multiple sclerosis (MS). Remarkably, IL-1 beta-knockout mice are highly resistant to experimental autoimmune encephalomyelitis (EAE), an animal model of MS. Here, we show that interfering with the IL-1 beta/IL-1R1 axis severely impairs the transmigration of myeloid cells across central nervous system (CNS) endothelial cells (ECs). Notably, we report that IL-1 beta expression by inflammatory CCR2(hi) monocytes favors their entry into the spinal cord before EAE onset. Following activation with IL-1 beta, CNS ECs release GM-CSF, which in turn converts monocytes into antigen-presenting cells (APCs). Accordingly, spinal cord-infiltrated monocyte-derived APCs are associated with dividing CD4(+) T cells. Factors released from the interaction between IL-1 beta-competent myeloid cells and CD4(+) T cells are highly toxic to neurons. Together, our results suggest that IL-1 beta signaling is an entry point for targeting both the initiation and exacerbation of neuroinflammation.